Total Payments
$7,348
2024 Payments
$360.16
Companies
22
Transactions
66
Payment Breakdown by Category
Food & Beverage$7,348 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,348 | 66 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $948.44 | 10 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $831.40 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $589.24 | 5 | $0 (2023) |
| Celgene Corporation | $503.45 | 4 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $447.11 | 4 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $416.95 | 4 | $0 (2019) |
| PFIZER INC. | $376.17 | 4 | $0 (2024) |
| Genentech USA, Inc. | $369.18 | 3 | $0 (2021) |
| BeiGene USA, Inc. | $352.29 | 3 | $0 (2024) |
| GENZYME CORPORATION | $352.00 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $360.16 | 3 | PFIZER INC. ($122.94) |
| 2023 | $369.68 | 3 | E.R. Squibb & Sons, L.L.C. ($134.81) |
| 2022 | $119.17 | 1 | Heron Therapeutics, Inc. ($119.17) |
| 2021 | $1,103 | 9 | Daiichi Sankyo Inc. ($227.73) |
| 2020 | $311.92 | 3 | GlaxoSmithKline, LLC. ($119.82) |
| 2019 | $1,862 | 17 | Incyte Corporation ($406.15) |
| 2018 | $2,454 | 22 | GENZYME CORPORATION ($352.00) |
| 2017 | $768.22 | 8 | Incyte Corporation ($246.69) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Oncology | ||||||
| 03/21/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $122.94 | General |
| Category: Oncology | ||||||
| 02/06/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $115.38 | General |
| Category: Oncology | ||||||
| 11/30/2023 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $134.81 | General |
| Category: Hematology | ||||||
| 10/03/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, CARVYKTI | Food and Beverage | In-kind items and services | $122.95 | General |
| Category: Oncology | ||||||
| 07/12/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $111.92 | General |
| Category: Oncology | ||||||
| 06/08/2022 | Heron Therapeutics, Inc. | Zynrelef (Drug) | Food and Beverage | In-kind items and services | $119.17 | General |
| Category: Postoperative Pain | ||||||
| 12/02/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $117.62 | General |
| 09/30/2021 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $139.18 | General |
| Category: BioOncology | ||||||
| 09/22/2021 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 08/03/2021 | Celgene Corporation | ONUREG (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Oncology | ||||||
| 07/28/2021 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $122.31 | General |
| Category: Hematology/Oncology | ||||||
| 07/13/2021 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $122.31 | General |
| 06/23/2021 | Epizyme, Inc., | TAZVERIK (Drug) | Food and Beverage | In-kind items and services | $123.50 | General |
| Category: ONCOLOGY | ||||||
| 06/02/2021 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $102.73 | General |
| Category: ONCOLOGY | ||||||
| 05/18/2021 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 03/05/2020 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $92.53 | General |
| Category: Oncology | ||||||
| 02/26/2020 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $119.82 | General |
| Category: ONCOLOGY | ||||||
| 02/03/2020 | PORTOLA PHARMACEUTICALS, LLC | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $99.57 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 12/17/2019 | Genentech USA, Inc. | Alecensa (Biological), ROZLYTREK | Food and Beverage | In-kind items and services | $120.74 | General |
| Category: BioOncology | ||||||
| 12/05/2019 | PFIZER INC. | TALZENNA (Drug) | Food and Beverage | In-kind items and services | $91.52 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $99.77 | General |
| Category: Oncology | ||||||
| 12/02/2019 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $114.99 | General |
| Category: Hematology/Oncology | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 10/17/2019 | EISAI INC. | Halaven (Drug) | Food and Beverage | Cash or cash equivalent | $108.20 | General |
| Category: Oncology | ||||||
About Dr. Edward Hearn, MD
Dr. Edward Hearn, MD is a Hematology & Oncology healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902984651.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Hearn, MD has received a total of $7,348 in payments from pharmaceutical and medical device companies, with $360.16 received in 2024. These payments were reported across 66 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($7,348).
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Sacramento, CA
- Active Since 11/01/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1902984651
Products in Payments
- JAKAFI (Drug) $948.44
- Abraxane (Drug) $378.45
- BRUKINSA (Drug) $352.29
- OPDIVO (Biological) $332.12
- KISQALI (Drug) $325.25
- LYNPARZA (Drug) $249.98
- Rubraca (Drug) $228.11
- Enhertu (Drug) $227.73
- SOLIRIS (Drug) $193.02
- TECENTRIQ (Biological) $139.18
- REBLOZYL (Biological) $134.81
- ONUREG (Drug) $125.00
- TAGRISSO (Drug) $124.99
- Onivyde (Drug) $124.51
- Lenvima (Drug) $124.13
- TAZVERIK (Drug) $123.50
- DARZALEX (Biological) $122.95
- PADCEV (Biological) $122.94
- NINLARO (Drug) $122.03
- Kyprolis (Biological) $121.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Sacramento
Dr. Joseph Tuscano, M.d, M.D
Hematology & Oncology — Payments: $633,262
Hematology & Oncology $633,262
Adam Giermasz, M.d., Phd, M.D., PHD
Hematology & Oncology — Payments: $518,605
Hematology & Oncology $518,605
Dr. David Gandara, M.d, M.D
Hematology & Oncology — Payments: $462,968
Hematology & Oncology $462,968
Dr. Scott Christensen, M.d, M.D
Hematology & Oncology — Payments: $391,606
Hematology & Oncology $391,606
Karen Kelly, M.d, M.D
Hematology & Oncology — Payments: $306,992
Hematology & Oncology $306,992
Paul Kaesberg, M.d, M.D
Hematology & Oncology — Payments: $221,939
Hematology & Oncology $221,939